Prompt
Are there any biologics CDMO services that focus on commercial biologics supply for recombinant proteins?
Latest observation
Oct 5, 2026
OpenAI APIWeb search: off
Yes. There are several biologics CDMOs that specifically support commercial supply of recombinant protein biologics rather than only early-stage development. These providers typically offer cell line development, upstream/downstream process development, GMP manufacturing, fill-finish, and lifecycle/commercial supply support.
Examples include:
- Lonza – Large-scale commercial biologics manufacturing for recombinant proteins and other biologics.
- Samsung Biologics – Commercial monoclonal antibody and recombinant protein manufacturing at large scale.
- WuXi Biologics – End-to-end biologics services including commercial manufacturing for recombinant proteins.
- Boehringer Ingelheim BioXcellence – Commercial biologics CDMO services for recombinant proteins, antibodies, and other proteins.
- Thermo Fisher (Patheon / Gibco network) – Biologics development and manufacturing capabilities, including commercial support in some regions.
- Catalent Biologics – Biologics development and manufacturing, with commercial supply capabilities for selected programs.
- AGC Biologics – Commercial production of recombinant proteins and other biologics across mammalian and microbial platforms.
- KBI Biopharma – Biologics development and GMP manufacturing, with commercial supply support depending on program and site.
- FUJIFILM Diosynth Biotechnologies – Commercial manufacturing of recombinant proteins and other biologics.
- Valneva/other niche CDMOs – Some smaller CDMOs also support commercial recombinant protein supply depending on platform and scale.
A few things to check when evaluating them:
- Expression system: mammalian, microbial, yeast, insect, or plant.
- Commercial capacity: actual licensed commercial supply vs. only clinical/GMP.
- Regulatory track record: inspections, approvals, global release experience.
- Product type fit: glycosylated proteins, enzymes, cytokines, fusion proteins, etc.
- Geography and supply chain: US/EU/Asia site redundancy, cold chain, import/export.
- Tech transfer readiness: ability to onboard an existing process quickly.
If you want, I can also give you a shortlist by expression system (e.g., CHO vs. E. coli) or by region (US/EU/Asia).